Endurant Capital Management LP Mustang Bio, Inc. Transaction History

Endurant Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $2.69 Million - $4.6 Million	-892,027 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.66 - $4.18 $1.41 Million - $2.22 Million	-531,023 Reduced 37.32%	892,027 $3.38 Million
Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $1.97 Million - $2.54 Million	654,579 Added 85.18%	1,423,050 $4.48 Million
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $1.79 Million - $3.53 Million	768,471 New	768,471 $2.44 Million

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.